Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Anika Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $120.65M, up 5.3% year over year. For fiscal 2025 it was $112.82M, down 5.9% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $147.79M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.82M | -5.9% |
| FY2024 | Dec 31, 2024 | $119.91M | -0.7% |
| FY2023 | Dec 31, 2023 | $120.79M | +6.1% |
| FY2022 | Dec 31, 2022 | $113.83M | -23.0% |
| FY2021 | Dec 31, 2021 | $147.79M | +13.3% |
| FY2020 | Dec 31, 2020 | $130.46M | +13.8% |
| FY2019 | Dec 31, 2019 | $114.61M | +8.6% |
| FY2018 | Dec 31, 2018 | $105.56M | -6.9% |
| FY2017 | Dec 31, 2017 | $113.42M | +9.7% |
| FY2016 | Dec 31, 2016 | $103.38M | +11.2% |
| FY2015 | Dec 31, 2015 | $93.00M | -11.9% |
| FY2014 | Dec 31, 2014 | $105.60M | +40.6% |
| FY2013 | Dec 31, 2013 | $75.08M | +5.2% |
| FY2012 | Dec 31, 2012 | $71.36M | +10.2% |
| FY2011 | Dec 31, 2011 | $64.78M | +16.6% |
| FY2010 | Dec 31, 2010 | $55.56M | +38.4% |
| FY2009 | Dec 31, 2009 | $40.14M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.61M | +15.6% |
| Q1 FY2026 | Mar 31, 2026 | $29.61M | +13.2% |
| Q4 FY2025 | Dec 31, 2025 | $30.62M | +0.0% |
| Q3 FY2025 | Sep 30, 2025 | $27.82M | -5.9% |
| Q2 FY2025 | Jun 30, 2025 | $28.22M | -8.2% |
| Q1 FY2025 | Mar 31, 2025 | $26.17M | -9.8% |
| Q4 FY2024 | Dec 31, 2024 | $30.60M | -28.8% |
| Q3 FY2024 | Sep 30, 2024 | $29.56M | -28.7% |
| Q2 FY2024 | Jun 30, 2024 | $30.72M | -30.6% |
| Q1 FY2024 | Mar 31, 2024 | $29.02M | -23.5% |
| Q4 FY2023 | Dec 31, 2023 | $42.97M | +8.5% |
| Q3 FY2023 | Sep 30, 2023 | $41.47M | +3.0% |
| Q2 FY2023 | Jun 30, 2023 | $44.30M | +11.7% |
| Q1 FY2023 | Mar 31, 2023 | $37.92M | +3.4% |
| Q4 FY2022 | Dec 31, 2022 | $39.62M | +10.6% |
| Q3 FY2022 | Sep 30, 2022 | $40.26M | +1.8% |
| Q2 FY2022 | Jun 30, 2022 | $39.66M | +4.0% |
| Q1 FY2022 | Mar 31, 2022 | $36.69M | +7.0% |
| Q4 FY2021 | Dec 31, 2021 | $35.82M | +9.6% |
| Q3 FY2021 | Sep 30, 2021 | $39.54M | +24.7% |
| Q2 FY2021 | Jun 30, 2021 | $38.15M | +24.3% |
| Q1 FY2021 | Mar 31, 2021 | $34.29M | -3.1% |
| Q4 FY2020 | Dec 31, 2020 | $32.69M | +9.8% |
| Q3 FY2020 | Sep 30, 2020 | $31.69M | +6.7% |
| Q2 FY2020 | Jun 30, 2020 | $30.68M | +0.9% |
| Q1 FY2020 | Mar 31, 2020 | $35.40M | +43.2% |
| Q4 FY2019 | Dec 31, 2019 | $29.77M | +10.4% |
| Q3 FY2019 | Sep 30, 2019 | $29.70M | +10.9% |
| Q2 FY2019 | Jun 30, 2019 | $30.42M | -0.4% |
| Q1 FY2019 | Mar 31, 2019 | $24.72M | +16.3% |
| Q4 FY2018 | Dec 31, 2018 | $26.96M | -8.3% |
| Q3 FY2018 | Sep 30, 2018 | $26.79M | -1.5% |
| Q2 FY2018 | Jun 30, 2018 | $30.55M | -8.7% |
| Q1 FY2018 | Mar 31, 2018 | $21.26M | -9.1% |
| Q4 FY2017 | Dec 31, 2017 | $29.39M | +2.3% |
| Q3 FY2017 | Sep 30, 2017 | $27.18M | +5.4% |
| Q2 FY2017 | Jun 30, 2017 | $33.46M | – |
| Q1 FY2017 | Mar 31, 2017 | $23.39M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.73M | – |
| Q3 FY2016 | Sep 30, 2016 | $25.79M | – |
See a number that looks wrong?